NCT02211157View on ClinicalTrials.gov

Safety, Pharmacokinetics and Pharmacodynamics of BIRB 796 BS Tablets Administered to Healthy Human Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

July 31, 2000

Conditions
Healthy
Interventions
DRUG

BIBR 796 BS

DRUG

Placebo

OTHER

high fat breakfast

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY